CA2106193A1 - Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques - Google Patents

Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques

Info

Publication number
CA2106193A1
CA2106193A1 CA 2106193 CA2106193A CA2106193A1 CA 2106193 A1 CA2106193 A1 CA 2106193A1 CA 2106193 CA2106193 CA 2106193 CA 2106193 A CA2106193 A CA 2106193A CA 2106193 A1 CA2106193 A1 CA 2106193A1
Authority
CA
Canada
Prior art keywords
cells
granzyme
perforin
antibodies
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2106193
Other languages
English (en)
French (fr)
Inventor
Marilyne Sasportes
Jurg Tschopp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2106193A1 publication Critical patent/CA2106193A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA 2106193 1991-03-14 1992-03-16 Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques Abandoned CA2106193A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103108A FR2673952A1 (fr) 1991-03-14 1991-03-14 Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques.
FR91/03108 1991-03-14

Publications (1)

Publication Number Publication Date
CA2106193A1 true CA2106193A1 (fr) 1992-09-15

Family

ID=9410734

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2106193 Abandoned CA2106193A1 (fr) 1991-03-14 1992-03-16 Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques

Country Status (5)

Country Link
EP (1) EP0575539A1 (enrdf_load_stackoverflow)
JP (1) JPH06506112A (enrdf_load_stackoverflow)
CA (1) CA2106193A1 (enrdf_load_stackoverflow)
FR (1) FR2673952A1 (enrdf_load_stackoverflow)
WO (1) WO1992016644A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2887060B2 (ja) * 1993-06-30 1999-04-26 日清製粉株式会社 グリセンチンの生産方法
US5858758A (en) * 1997-05-07 1999-01-12 Incyte Pharmaceuticals, Inc. Human serine protease precursor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783410A (en) * 1985-06-28 1988-11-08 Massachusetts Institute Of Technology Cytotoxic t lymphocyte serine esterase and method for stimulation and inhibition
EP0245051B1 (en) * 1986-05-06 1992-08-12 The Board Of Trustees Of The Leland Stanford Junior University Killer cell cytotoxic composition

Also Published As

Publication number Publication date
WO1992016644A1 (fr) 1992-10-01
EP0575539A1 (fr) 1993-12-29
FR2673952A1 (fr) 1992-09-18
JPH06506112A (ja) 1994-07-14
FR2673952B1 (enrdf_load_stackoverflow) 1995-05-12

Similar Documents

Publication Publication Date Title
JP7539434B2 (ja) トランスフォーミング増殖因子ベータ応答性ポリペプチド及びその使用方法
JP6767931B2 (ja) Ｔ細胞受容体ベータ定常領域に対する抗原結合ドメインを有するキメラ抗原抗体（ｃａｒ）
JP3479892B2 (ja) 新しいヒトヘマトポエチン受容体、Ｈｕ−Ｂ１．２１９
EP0942973B1 (fr) Mutants de la proteine lag-3, leur expression et utilisation
KR20200023288A (ko) 신규 t 세포 수용체 및 이를 사용하는 면역 요법
FR2656800A1 (fr) Nouvelles proteines produits par les lymphocytes humains, sequence d'adn codant pour ces proteines et applications pharmaceutiques et biologiques.
JPH10512440A (ja) サイトカイン”ｌｅｒｋ−７”
US20070065882A1 (en) Acetylcholinesterase-derived peptides and uses thereof
JP2002543787A (ja) 白血球免疫グロブリン様受容体（ｌｉｒ）と命名された免疫調節因子のファミリー
CN113195526B (zh) 针对过继性t细胞疗法中的突变myd88l265p蛋白表位的特异性t细胞受体
JPH07502496A (ja) Ｃｄ２／ｌｆａ−３相互作用の阻害剤を用いる抗原提示細胞による皮膚障害の予防または治療の方法
JP2001523099A (ja) 白血球免疫グロブリン様受容体（ｌｉｒ）と命名される免疫調節剤ファミリー
US20040072259A1 (en) Methods and products for manipulating hematopoietic stem cells
JPH10507369A (ja) ウィルス、特にレトロウィルスの複製を阻害するためへの“免疫不全ウィルス抑制リンフォカイン（ｉｓｌ）”の使用
EP1638596A2 (fr) Utilisation de compositions contenant une forme soluble d' hla-g dans le traitement de pathologies du sang
CA2106193A1 (fr) Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques
CN120019146A (zh) 通用t细胞和组合物及它们的使用方法
EP1228212B1 (fr) Proteine presente a la surface des cellules souches hematopoietiques de la lignee lymphoide et des cellules nk, et ses applications.
LU86718A1 (fr) Nouveau facteur pour la regulation de la croissance cellulaire
WO2023154890A2 (en) Chimeric antigen receptors binding steap1
WO2001096564A2 (fr) Isoforme d'hla-g (hla-g7) et ses applications
US20080057579A1 (en) Methods and products for manipulating hematopoietic stem cells
JP3796780B2 (ja) 新規免疫抑制剤
US20250263461A1 (en) Recombinant t-cell receptors that bind the ny-eso-1 and/or lage-1a cancer antigens
Giezeman‐Smits et al. Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL‐2‐activated rat NK cells

Legal Events

Date Code Title Description
FZDE Dead